Handelsavisen
prelaunch
Companies Basic Materials 300721.SZ
30
300721.SZ Shenzhen Stock Exchange Commodity Chemicals

Jiang Su Yida Chemical Co Ltd

¥10,29
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,7B CNY
P/E
EV / Rev
3,6x
Div yield
0,00 %
Op margin
1,5 %
ROE
0,6 %
Net margin
1,6 %
Debt / equity
0,84
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Jiang Su Yida Chemical Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Business. Jiang Su Yida Chemical Co Ltd (300721.SZ) is a Chinese chemical manufacturer operating within the commodity chemicals industry. The company is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
0,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 300721.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 300721.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Jiang Su Yida Chemical Co Ltd (300721.SZ) is a Chinese chemical manufacturer operating within the commodity chemicals industry. The company is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryCommodity Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Jiang Su Yida Chemical Co Ltd has a market capitalization of 4.7 billion CNY and a price-to-earnings ratio of 611.75, indicating a high valuation relative to its earnings. The company's liquidity position is assessed as medium, with a current ratio of 0.54, suggesting that it has less than one CNY of current assets for every CNY of current liabilities. The debt-to-equity ratio of 0.84 indicates a moderate level of leverage, with long-term debt accounting for a significant portion of its capital structure.

    The company's profitability is relatively low, with a return on equity of 0.63% and a return on assets of 0.3%, both of which are below the typical thresholds for healthy returns in the commodity chemicals industry. The operating margin is 1.45% (calculated as operating income of 6.85 million CNY divided by revenue of 470.72 million CNY), which is also below the median for the industry. The gross margin of 8.87% (calculated as gross profit of 41.78 million CNY divided by revenue of 470.72 million CNY) is similarly low, indicating that the company is facing significant cost pressures.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic fluctuations and regulatory changes in China. The company's operating cash flow of 68.71 million CNY is positive, but it is not sufficient to cover its capital expenditures of 45.02 million CNY, indicating that the company is reinvesting in its operations.

    The company's growth trajectory is uncertain, with no specific revenue growth targets or projections provided in the available data. The company's high price-to-earnings ratio and low profitability suggest that it may be overvalued relative to its earnings potential. The company's capital expenditures are primarily directed toward maintaining and expanding its production capacity, which is a common practice in the commodity chemicals industry.

    The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing. The company has not issued any new shares in the recent period, and there is no indication of dilution pressure in the near term.

    The company has not disclosed any material recent events, such as new product launches, regulatory changes, or significant business developments, that would impact its financial performance or strategic direction. The company's financial statements do not indicate any material changes in its business operations or financial position in the most recent reporting period.

    Key takeaways
    • The company has a high price-to-earnings ratio of 611.75, indicating a high valuation relative to its earnings.
    • The company's profitability is low, with a return on equity of 0.63% and a return on assets of 0.3%.
    • The company's liquidity position is medium, with a current ratio of 0.54.
    • The company's revenue is concentrated in a single business segment, increasing its exposure to regional economic fluctuations.
    • The company's capital expenditures are primarily directed toward maintaining and expanding its production capacity.
    • The company has a low dilution risk, with no new shares issued in the recent period.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    The company generated CNY 1.6 billion in revenue in the latest period, demonstrating significant scale in the commodity chemicals sector.

    Cash conversion metrics rank as best-in-class compared to the commodity chemicals cohort median, indicating superior operational efficiency.

    Dilution risk is assessed as low, suggesting limited immediate threat to existing shareholder equity value from share issuance.

    BEAR CASE · 3

    The debt-to-equity ratio of 0.84 sits in the bottom quartile of the cohort, indicating excessive leverage.

    Credit risk is flagged as high, raising concerns about the company's ability to meet its financial obligations.

    Return on equity of 0.63% trails the cohort median of 3.61%, showing poor capital efficiency relative to peers.

    In focus — financials by report

    Annual
    ANNUALFiled 2023-02-20
    FY 2023 · Full-year highlights

    Revenue ¥1.55B, +7,2% YoY; Operating income −21,9% YoY.

    Revenue¥1.55B+7,2 % YoY
    Operating income¥126.5M−21,9 % YoY
    Net income¥109.6M−16,9 % YoY
    Free cash flow-¥99.3M+26,2 % YoY
    EPS
    Operating cash flow¥137.0M−48,5 % YoY
    Financials
    Income statement
    Revenue¥1.55B
    Gross profit¥287.9M
    Operating income¥126.5M
    Net income¥109.6M
    Margins
    Gross margin18.5%
    Operating margin8.1%
    Net margin7.1%
    FCF margin-6.4%
    Balance sheet
    Total assets¥2.86B
    Total liabilities¥1.60B
    Total equity¥1.25B
    Cash & equivalents
    Long-term debt¥1.00B
    Cash flow
    Operating cash flow¥137.0M
    CapEx-¥220.2M
    Free cash flow-¥99.3M
    SBC
    P&L flow · revenue → net income
    Revenue ¥470.7MOperating costs ¥463.9MFinance ¥11.5MNet income ¥7.7M
    Highlights
    • Revenue ¥1.55B, +7,2% YoY
    • Operating income −21,9% YoY
    • Net income −16,9% YoY
    • Free cash flow +26,2% YoY
    • Net margin 7.1%

    Valuation FY

    Market price
    ¥10,29
    Market cap
    ¥4.70B
    Enterprise value
    ¥5.73B
    P/E
    Non-GAAP P/E
    EV / Revenue
    3.6x
    EV / Op income
    EV / OCF
    83.4x
    P / B
    3.9x
    P / Tangible book
    3.9x
    Tangible book
    ¥1.22B
    Net cash
    -¥1.03B
    Current ratio
    0.5
    Debt / equity
    0.8
    ROA
    0.3%
    ROE
    0.6%
    Cash conversion
    893.0%
    CapEx / revenue
    -9.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin1,5 %Below median
    Net Margin1,6 %Below median
    ROE0,6 %Below median
    Capex / Rev-9,6 %Below median
    D/E0,84Bottom quartile
    Cash Conv8,93Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Jiang Su Yida Chemical Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    300721.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2023-02-20 15:19 UTCEARNINGSAnnual results — FY 2023 Revenue CNY 1.55B · Net CNY 109.6M
    2022-03-14 16:09 UTCEARNINGSAnnual results — FY 2022 Revenue CNY 1.45B · Net CNY 131.8M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage